Transition Agreements
Health Care Providers & Services
Health Care Providers & Services (23) | Transition Agreements (771)
- Addus HomeCare Corp (2 contracts)
- AGILITI, INC. (1)
- American Renal Associates Holdings, Inc. (1)
- Amn Healthcare Services Inc (1)
- Centene Corporation (2)
- DaVita Inc. (1)
- DFB Healthcare Acquisitions Corp. (1)
- Encompass Health Corp. (1)
- Enhabit, Inc. (1)
- GE Healthcare Holding LLC (1)
- Interpace Diagnostics Group, Inc. (1)
- Laboratory Corp. of America Holding (1)
- Pennant Group, Inc. (1)
- PetIQ, Inc. (5)
- Privia Health Group, Inc. (1)
- The Ensign Group, Inc. (1)
- XLR MEDICAL CORP. (1)
- Transition Letter Agreement, between AdaptHealth Corp. and Stephen P. Griggs, dated May 8, 2023 (DFB Healthcare Acquisitions Corp., Filed With SEC on May 9, 2023)
- Transition Agreement, dated as of January 6, 2023, by and between Agiliti, Inc. and Thomas J. Leonard (AGILITI, INC., Filed With SEC on January 9, 2023)
- Transition Services Agreement, dated January 2, 2023 by and between General Electric Company and GE HealthCare Technologies Inc. (f/k/a GE Healthcare Holding LLC) (GE Healthcare Holding LLC, Filed With SEC on January 4, 2023)
- TRANSITION SERVICES AGREEMENT (XLR MEDICAL CORP., Filed With SEC on October 31, 2022)
- Transition Services Agreement, dated as of June 30, 2022, by and between Encompass Health Corporation and Enhabit, Inc (Encompass Health Corp., Filed With SEC on July 7, 2022)
- Transition Services Agreement, dated as of June 30, 2022, by and between Encompass Health Corporation and Enhabit, Inc (Enhabit, Inc., Filed With SEC on July 5, 2022)
- Transition Support Agreement and General Release, between PetIQ, Inc., and Susan Sholtis (PetIQ, Inc., Filed With SEC on May 19, 2022)
- Form of Transition Support Agreement and General Release, between PetIQ, Inc., and Susan Sholtis (PetIQ, Inc., Filed With SEC on May 9, 2022)
- Transition Agreement, dated as of May 5, 2022, between AMN Healthcare, Inc. and Susan R. Salka (Management Contract or Compensatory Plan or Arrangement) (Amn Healthcare Services Inc, Filed With SEC on May 6, 2022)
- Transition Agreement between Centene Corporation and Jesse Hunter, dated October 26, 2021 (Centene Corporation, Filed With SEC on February 22, 2022)
- Transition Letter Agreement, dated as of January 6, 2022, between the Company and David Mountcastle (Privia Health Group, Inc., Filed With SEC on January 6, 2022)
- Transition Support Agreement and General Release, dated as of August 3, between PetIQ, Inc., and John Newland (PetIQ, Inc., Filed With SEC on August 12, 2021)
- Transition Support Agreement and General Release, dated as of August 3, between PetIQ, Inc., and John Newland (PetIQ, Inc., Filed With SEC on August 10, 2021)
- Transition Agreement and Release, effective June 11, 2021, by and among Addus HealthCare, Inc. and Laurie Manning (Addus HomeCare Corp, Filed With SEC on August 4, 2021)
- Transition Services Agreement between Centene Corporation and Kenneth Burdick, dated February (Centene Corporation, Filed With SEC on February 22, 2021)
- Transition Agreement, dated October 1, 2020, by and between DaVita Inc. and LeAnne Zumwalt (DaVita Inc., Filed With SEC on October 29, 2020)
- Transition Services Agreement between Joseph A. Carlucci and the Company, dated March 13, 2020 (American Renal Associates Holdings, Inc., Filed With SEC on March 16, 2020)
- Transition Services Agreement, dated as of October 1, 2019, by and between The Ensign Group, Inc. and The Pennant Group, Inc (Pennant Group, Inc., Filed With SEC on October 3, 2019)
- Transition Services Agreement, dated as of October 1, 2019, by and between The Ensign Group, Inc. and The Pennant Group, Inc (The Ensign Group, Inc., Filed With SEC on October 1, 2019)
- Transition Agreement David P. King (Laboratory Corp. of America Holding, Filed With SEC on August 8, 2019)
- Transition Agreement and Release, effective as of July 31, 2019, by and between Addus HealthCare, Inc. and James Zeke Zoccoli (Addus HomeCare Corp, Filed With SEC on July 24, 2019)
- Transition Services Agreement, dated July 15, 2019, by and between Interpace BioPharma, Inc. and Cancer Genetics, Inc (Interpace Diagnostics Group, Inc., Filed With SEC on July 19, 2019)
- Transition Services Agreement, dated July 8, 2019, by and between PetIQ, LLC and L. Perrigo Company (PetIQ, Inc., Filed With SEC on July 9, 2019)